Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
Han WangJun ChenXin ZhangXia ShengXiao-Yan ChangJie ChenMin-Shan ChenHui DongGuang-Jie DuanHe-Ping HuZhi-Yong HuangWei-Dong JiaXiao-Qing JiangDong KuangShan-Shan LiZeng-Shan LiChang-Li LuShu-Kui QinXue-Shan QiuLi-Juan QuChun-Kui ShaoFeng ShenGuo-Ming ShiSu-Sheng ShiYu-Jun ShiHui-Chuan SunXiao-Dong TengBin WangZhan-Bo WangTian-Fu WenJia-Mei YangQiao-Qiao YangSheng-Long YeHong-Fang YinZhen-Gang YuanJing-Ping YunFeng-Lin ZangHong-Qi ZhangLi-Hong ZhangJing-Min ZhaoJian ZhouWei-Xun ZhouJia FanXiao-Ping ChenWan Yee LauYuan JiWen-Ming Congnull nullPublished in: Journal of clinical and translational hepatology (2023)
Intrahepatic cholangiocarcinoma (iCCA) can originate from the large bile duct group (segment bile ducts and area bile ducts), small bile duct group (septal bile ducts and interlobular bile ducts), and terminal bile duct group (bile ductules and canals of Hering) of the intrahepatic biliary tree, which can be histopathological corresponding to large duct type iCCA, small duct type iCCA and iCCA with ductal plate malformation pattern, and cholangiolocarcinoma, respectively. The challenge in pathological diagnosis of above subtypes of iCCA falls in the distinction of cellular morphologies, tissue structures, growth patterns, invasive behaviors, immunophenotypes, molecular mutations, and surgical prognoses. For these reasons, this expert consensus provides nine recommendations as a reference for standardizing and refining the diagnosis of pathological subtypes of iCCA, mainly based on the 5 th edition of the World Health Organization Classification of Tumours of the Digestive System.
Keyphrases